Compass Pathways Announces U.S Grant Program for the Creation of Post-Approval COMP360 Provider Training

Contributed by: Business Wire

Logo

Tags

Mental Health

Research

Clinical Trials

Biotechnology

Alternative Medicine

Health

Pharmaceutical

Other Science

Science

Grant

More Like This

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights

Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit

Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments